Literature DB >> 12791863

Shiga toxin 1c-producing Escherichia coli strains: phenotypic and genetic characterization and association with human disease.

Alexander W Friedrich1, Julia Borell, Martina Bielaszewska, Angelika Fruth, Helmut Tschäpe, Helge Karch.   

Abstract

The distribution of the stx(1c) allele among Shiga toxin (Stx)-producing Escherichia coli (STEC) and the virulence characteristics of stx(1c)-harboring STEC are unknown. In this study, we identified stx(1c) in 76 (54.3%) of 140 eae-negative, but in none of 155 eae-positive, human STEC isolates (P < 0.000001). The 76 stx(1c)-harboring E. coli isolates belonged to 22 serotypes, and each produced Stx1c as demonstrated by latex agglutination. Characterization of putative virulence factors demonstrated the presence of the locus of proteolysis activity (LPA) and the high-pathogenicity island in 65.8 and 21.1%, respectively, of the 76 Stx1c-producing E. coli isolates. Moreover, all but three of these strains contained saa, the gene encoding an STEC autoagglutinating adhesin. The virulence profiles of Stx1c-producing E. coli isolates were mostly serotype independent and heterogeneous. This enabled us to subtype the isolates within the same serotype. The individuals infected with Stx1c-producing E. coli strains were between 3 months and 72 years old (median age, 23.5 years) and usually had uncomplicated diarrhea or were asymptomatic. We conclude that Stx1c-producing E. coli strains represent a significant subset of eae-negative human STEC isolates, which belong to various serotypes and frequently possess LPA and saa as their putative virulence factors. The phenotypic and molecular characteristics determined in this study allow the subtyping of Stx1c-producing STEC in epidemiological and clinical studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791863      PMCID: PMC156474          DOI: 10.1128/JCM.41.6.2448-2453.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  36 in total

1.  Molecular characteristics and epidemiological significance of Shiga toxin-producing Escherichia coli O26 strains.

Authors:  W L Zhang; M Bielaszewska; A Liesegang; H Tschäpe; H Schmidt; M Bitzan; H Karch
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.

Authors:  Alexander W Friedrich; Martina Bielaszewska; Wen-Lan Zhang; Matthias Pulz; Thorsten Kuczius; Andrea Ammon; Helge Karch
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

3.  The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.

Authors:  C S Wong; S Jelacic; R L Habeeb; S L Watkins; P I Tarr
Journal:  N Engl J Med       Date:  2000-06-29       Impact factor: 91.245

4.  Isolation of a lysogenic bacteriophage carrying the stx(1(OX3)) gene, which is closely associated with Shiga toxin-producing Escherichia coli strains from sheep and humans.

Authors:  C Koch; S Hertwig; R Lurz; B Appel; L Beutin
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

5.  A genomic island, termed high-pathogenicity island, is present in certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages.

Authors:  H Karch; S Schubert; D Zhang; W Zhang; H Schmidt; T Olschläger; J Hacker
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

6.  Identification and characterization of a novel genomic island integrated at selC in locus of enterocyte effacement-negative, Shiga toxin-producing Escherichia coli.

Authors:  H Schmidt; W L Zhang; U Hemmrich; S Jelacic; W Brunder; P I Tarr; U Dobrindt; J Hacker; H Karch
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

7.  Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans.

Authors:  A W Paton; P Srimanote; M C Woodrow; J C Paton
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

8.  Iha: a novel Escherichia coli O157:H7 adherence-conferring molecule encoded on a recently acquired chromosomal island of conserved structure.

Authors:  P I Tarr; S S Bilge; J C Vary; S Jelacic; R L Habeeb; T R Ward; M R Baylor; T E Besser
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

9.  Molecular characterization of a Shiga toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of cases of hemolytic-uremic syndrome.

Authors:  A W Paton; M C Woodrow; R M Doyle; J A Lanser; J C Paton
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

10.  A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from pigeons.

Authors:  H Schmidt; J Scheef; S Morabito; A Caprioli; L H Wieler; H Karch
Journal:  Appl Environ Microbiol       Date:  2000-03       Impact factor: 4.792

View more
  43 in total

1.  Characterization of cytolethal distending toxin genes and expression in shiga toxin-producing Escherichia coli strains of non-O157 serogroups.

Authors:  Martina Bielaszewska; Marina Fell; Lilo Greune; Rita Prager; Angelika Fruth; Helmut Tschäpe; M Alexander Schmidt; Helge Karch
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

2.  Characterization of urinary tract infection-associated Shiga toxin-producing Escherichia coli.

Authors:  Francisco Toval; Roswitha Schiller; Iris Meisen; Johannes Putze; Ivan U Kouzel; Wenlan Zhang; Helge Karch; Martina Bielaszewska; Michael Mormann; Johannes Müthing; Ulrich Dobrindt
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

3.  Genome signatures of Escherichia coli O157:H7 isolates from the bovine host reservoir.

Authors:  Mark Eppinger; Mark K Mammel; Joseph E Leclerc; Jacques Ravel; Thomas A Cebula
Journal:  Appl Environ Microbiol       Date:  2011-03-18       Impact factor: 4.792

4.  Verotoxins in bovine and meat verotoxin-producing Escherichia coli isolates: type, number of variants, and relationship to cytotoxicity.

Authors:  Alejandra Krüger; Paula M A Lucchesi; Alberto E Parma
Journal:  Appl Environ Microbiol       Date:  2010-10-29       Impact factor: 4.792

5.  Serotypes and virulence profiles of non-O157 Shiga toxin-producing Escherichia coli isolates from bovine farms.

Authors:  Aine Monaghan; Brian Byrne; Séamus Fanning; Torres Sweeney; David McDowell; Declan J Bolton
Journal:  Appl Environ Microbiol       Date:  2011-10-14       Impact factor: 4.792

6.  Cytolethal distending toxin from Shiga toxin-producing Escherichia coli O157 causes irreversible G2/M arrest, inhibition of proliferation, and death of human endothelial cells.

Authors:  Martina Bielaszewska; Bhanu Sinha; Thorsten Kuczius; Helge Karch
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

7.  Prevalences of Shiga toxin subtypes and selected other virulence factors among Shiga-toxigenic Escherichia coli strains isolated from fresh produce.

Authors:  Peter C H Feng; Shanker Reddy
Journal:  Appl Environ Microbiol       Date:  2013-08-30       Impact factor: 4.792

8.  Specificity of PCR and serological assays in the detection of Escherichia coli Shiga toxin subtypes.

Authors:  Peter C H Feng; Karen Jinneman; Flemming Scheutz; Steven R Monday
Journal:  Appl Environ Microbiol       Date:  2011-07-29       Impact factor: 4.792

9.  Serotypes and virulence gene profiles of shiga toxin-producing Escherichia coli strains isolated from feces of pasture-fed and lot-fed sheep.

Authors:  Steven P Djordjevic; Vidiya Ramachandran; Karl A Bettelheim; Barbara A Vanselow; Peter Holst; Graham Bailey; Michael A Hornitzky
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

10.  Bacteriophage 2851 is a prototype phage for dissemination of the Shiga toxin variant gene 2c in Escherichia coli O157:H7.

Authors:  Eckhard Strauch; Jens Andre Hammerl; Antje Konietzny; Susanne Schneiker-Bekel; Walter Arnold; Alexander Goesmann; Alfred Pühler; Lothar Beutin
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.